CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-17). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2707 · Search date 2026-08-17 · Methodology v0.7

CPC-essential-oil mouth rinse,
does it really help with Reduced plaque re-accumulation after professional prophylaxis?

30-Second Summary
C
Evidence Grade C · 50 · Safety caution
Plaque fell, but gingival outcomes did not improve and 32% of randomized participants were excluded from analysis
Staining, oral lesions, altered taste, and irritation occurred, with some discontinuations. Persistent pain, ulceration, or swelling warrants stopping use and dental review.
What the
research shows
The grade is C with 50 points. Among 80 completers from 118 randomized participants, plaque scores were 2.32 versus 2.55 at week 6 and 2.34 versus 2.61 at week 12, with an overall treatment effect of P=.022. Plaque is a process surrogate rather than caries, periodontitis, tooth loss, or another patient event, and the other registered primary clinical measures did not improve.
What the
ads claim
A lower plaque score is real but does not establish prevention of gingivitis, caries, periodontitis, or tooth loss. Direct gingival outcomes did not improve here.
*

Useful facts when choosing a product

  • The rinse combined CPC, cinnamaldehyde, menthol, eucalyptol, methyl salicylate, thymol, and an alkaline hyperosmotic formulation.
  • Participants rinsed with 20 mL for 30 seconds twice daily for 12 weeks.
  • Adverse events occurred in 22/59 with test rinse and 11/59 with control, including staining, oral lesions, and altered taste.
Gap Measurement · Verdict 2707 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

This single-center double-blind carrier-controlled trial randomized 118 participants, 59 per group. Seventeen were lost to follow-up and 21 discontinued treatment, leaving a completer analysis of 80, 39 versus 41, and excluding 32.2% of randomized participants. Completer analysis, substantial exclusion, and total enrollment below 200 are avoidable limitations. Funding combined Next Science with VA, NIAID, and Gatorade Trust support; the company supplied the randomization schedule. Two company employees were coauthors and participated in interpretation and manuscript work.

02

Why this is classified as C (50)

Only the plaque surrogate improved among multiple registered primary measures, while 32.2% exclusion and completer analysis limit confidence, giving C with 50 points.

Counterpoint. This result applies to the tested combination and is not a class effect for every CPC or essential-oil rinse.

Rejudgment record. Cross-check applied — Cross-checked the paper against NCT03154021 for multiple registered primary outcomes, paper reclassification, 80-person completer analysis, funding, and company roles

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced plaque re-accumulationCA moderate reduction appeared in completers, but plaque is a surrogate.
Improved gingivitis, bleeding, and pocket depthDThe other registered primary clinical measures showed no between-group benefit.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Newman BA, Rosebrough CN, Tamashiro RA, Dias Ribeiro AP, Whitlock JA, Sidhu G, Aukhil I, Porral DY, Progulske-Fox A, Myntti MF, Wang GP. 2022Single-center randomized double-blind carrier-controlled parallel trial41Mixed support from Next Science, a VA Merit Award, NIAID, and the Gatorade Trust; company supplied the allocation scheduleRegistry listed plaque, gingival index, bleeding, and pocket depth as primary; paper reclassified plaque alone as primaryPlaque treatment effect P=.022; gingivitis P=.34, with bleeding and pocket depth nullSingle trial with partial surrogate success and completer analysis
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-17).

Newman BA, Rosebrough CN, Tamashiro RA, Dias Ribeiro AP, Whitlock JA, Sidhu G, Aukhil I, Porral DY, Progulske-Fox A, Myntti MF, Wang GP. A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitis. BMC Oral Health. 2022;22:461. PMID: 36324127. DOI: 10.1186/s12903-022-02518-2. NCT03154021.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-17 · Corrections: none

Cite this verdict

CPC-essential-oil mouth rinse x plaque re-accumulation Evidence Grade C card
[Chamgap] CPC-essential-oil mouth rinse x plaque re-accumulation — Evidence Grade C·50. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/general/cpc-essential-oil-mouth-rinse-plaque-reaccumulation/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.